253 related articles for article (PubMed ID: 30486276)
81. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.
Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W
Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540
[TBL] [Abstract][Full Text] [Related]
82. Capecitabine loaded potato starch-chitosan nanoparticles: A novel approach for targeted therapy and improved outcomes in aggressive colon cancer.
Bhattacharya S; Page A; Shinde P
Eur J Pharm Biopharm; 2024 Jul; 200():114328. PubMed ID: 38763329
[TBL] [Abstract][Full Text] [Related]
83. DNA-Hybrid-Gated Photothermal Mesoporous Silica Nanoparticles for NIR-Responsive and Aptamer-Targeted Drug Delivery.
Zhang Y; Hou Z; Ge Y; Deng K; Liu B; Li X; Li Q; Cheng Z; Ma P; Li C; Lin J
ACS Appl Mater Interfaces; 2015 Sep; 7(37):20696-706. PubMed ID: 26325285
[TBL] [Abstract][Full Text] [Related]
84. Sunitinib loaded chitosan nanoparticles formulation and its evaluation.
Joseph JJ; Sangeetha D; Gomathi T
Int J Biol Macromol; 2016 Jan; 82():952-8. PubMed ID: 26522243
[TBL] [Abstract][Full Text] [Related]
85. Study of the anti-cancer activity of a mesoporous silica nanoparticle surface coated with polydopamine loaded with umbelliprenin.
Edalatian Tavakoli S; Motavalizadehkakhky A; Homayouni Tabrizi M; Mehrzad J; Zhiani R
Sci Rep; 2024 May; 14(1):11450. PubMed ID: 38769394
[TBL] [Abstract][Full Text] [Related]
86. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
[TBL] [Abstract][Full Text] [Related]
87. Electrophoretic deposition of GHK-Cu loaded MSN-chitosan coatings with pH-responsive release of copper and its bioactivity.
Ning C; Jiajia J; Meng L; Hongfei Q; Xianglong W; Tingli L
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109746. PubMed ID: 31500015
[TBL] [Abstract][Full Text] [Related]
88. Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.
Cheng MR; Li Q; Wan T; He B; Han J; Chen HX; Yang FX; Wang W; Xu HZ; Ye T; Zha BB
World J Gastroenterol; 2012 Nov; 18(42):6076-87. PubMed ID: 23155336
[TBL] [Abstract][Full Text] [Related]
89. A self-targeting and controllable drug delivery system constituting mesoporous silica nanoparticles fabricated with a multi-stimuli responsive chitosan-based thin film layer.
Chen C; Yao W; Sun W; Guo T; Lv H; Wang X; Ying H; Wang Y; Wang P
Int J Biol Macromol; 2019 Feb; 122():1090-1099. PubMed ID: 30219514
[TBL] [Abstract][Full Text] [Related]
90.
Sun R; Fang L; Lv X; Fang J; Wang Y; Chen D; Wang L; Chen J; Qi Y; Tang Z; Zhang J; Tian Y
Drug Deliv; 2021 Dec; 28(1):2071-2084. PubMed ID: 34595970
[TBL] [Abstract][Full Text] [Related]
91. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
Al-Nadaf AH; Dahabiyeh LA; Jawarneh S; Bardaweel S; Mahmoud NN
Pharm Dev Technol; 2021 Jun; 26(5):582-591. PubMed ID: 33729906
[TBL] [Abstract][Full Text] [Related]
92. Facile synthesis by a covalent binding reaction for pH-responsive drug release of carboxylated chitosan coated hollow mesoporous silica nanoparticles.
Liu Q; Wang J; Yang L; Xia X; Wang M; Chen S; Zhu R; Wang Q; Wu X; Wang S
IET Nanobiotechnol; 2018 Jun; 12(4):446-452. PubMed ID: 29768228
[TBL] [Abstract][Full Text] [Related]
93. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.
Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP
ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774
[TBL] [Abstract][Full Text] [Related]
94. Study of 5-Fluorouracil Loaded Chitosan Nanoparticles for Treatment of Skin Cancer.
Patel G; Yadav BKN
Recent Pat Nanotechnol; 2020; 14(3):210-224. PubMed ID: 31267881
[TBL] [Abstract][Full Text] [Related]
95. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment.
Martínez-Carmona M; Lozano D; Colilla M; Vallet-Regí M
Acta Biomater; 2018 Jan; 65():393-404. PubMed ID: 29127069
[TBL] [Abstract][Full Text] [Related]
96. Development of insulin loaded mesoporous silica injectable particles layered by chitosan as a controlled release delivery system.
Elsayed A; Al-Remawi M; Maghrabi I; Hamaidi M; Jaber N
Int J Pharm; 2014 Jan; 461(1-2):448-58. PubMed ID: 24368103
[TBL] [Abstract][Full Text] [Related]
97. Targeted Anticancer Drug Delivery Using Chitosan, Carbon Quantum Dots, and Aptamers to Deliver Ganoderic Acid and 5-Fluorouracil.
Mazandarani A; Taravati A; Mohammadnejad J; Yazdian F
Chem Biodivers; 2023 Sep; 20(9):e202300659. PubMed ID: 37548485
[TBL] [Abstract][Full Text] [Related]
98. Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy.
Fang J; Zhang S; Xue X; Zhu X; Song S; Wang B; Jiang L; Qin M; Liang H; Gao L
Int J Nanomedicine; 2018; 13():5113-5126. PubMed ID: 30233175
[TBL] [Abstract][Full Text] [Related]
99. Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies.
Cheng M; Han J; Li Q; He B; Zha B; Wu J; Zhou R; Ye T; Wang W; Xu H; Hou Y
J Biomed Mater Res B Appl Biomater; 2012 Nov; 100(8):2035-43. PubMed ID: 22865703
[TBL] [Abstract][Full Text] [Related]
100. Large-Pore Functionalized Mesoporous Silica Nanoparticles as Drug Delivery Vector for a Highly Cytotoxic Hybrid Platinum-Acridine Anticancer Agent.
Zheng Y; Fahrenholtz CD; Hackett CL; Ding S; Day CS; Dhall R; Marrs GS; Gross MD; Singh R; Bierbach U
Chemistry; 2017 Mar; 23(14):3386-3397. PubMed ID: 28122141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
